Xiaotan Sanjie decoction normalizes tumor permissive microenvironment in gastric cancer (Review)
- Authors:
- Da-Zhi Sun
- Pin-Kang Wei
- Xiao-Qiang Yue
-
Affiliations: Department of Traditional Chinese Medicine, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, P.R. China - Published online on: February 28, 2023 https://doi.org/10.3892/or.2023.8511
- Article Number: 74
This article is mentioned in:
Abstract
 |
|
Cao W, Chen HD, Yu YW, Li N and Chen WQ: Changing profiles of cancer burden worldwide and in China: A secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 134:783–791. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 355:11–20. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, Kopp HG, Mayer F, Haag GM, Luley K, et al: Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): A randomised, phase 2/3 trial. Lancet. 393:1948–1957. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, et al: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial. Lancet. 376:687–697. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Sounni NE and Noel A: Targeting the tumor microenvironment for cancer therapy. Clin Chem. 59:85–93. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Quail DF and Joyce JA: Microenvironmental regulation of tumor progression and Metastasis. Nat Med. 19:1423–1437. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Oya Y, Hayakawa Y and Koike K: Tumor microenvironment in gastric cancers. Cancer Sci. 111:2696–2707. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Passalacqua R, Goswami C, Safran H, Dos Santos LV, Aprile G, Ferry DR, et al: Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): An international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 383:31–39. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kang YK, Boku N, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, et al: Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 390:2461–2471. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Fuchs CS, Doi T, Jang RW, Muro K, Satoh T, Machado M, Sun W, Jalal SI, Shah MA, Metges JP, et al: Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: Phase 2 clinical KEYNOTE-059 trial. JAMA Oncol. 4:e1800132018. View Article : Google Scholar : PubMed/NCBI | |
|
Wilke H, Muro K, Van Cutsem E, Oh SC, Bodoky G, Shimada Y, Hironaka S, Sugimoto N, Lipatov O, Kim TY, et al: Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): A double-blind, randomised phase 3 trial. Lancet Oncol. 15:1224–1235. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng YB, Cao FY, Liu KJ, Gan HF, He XB and Tong SL: Value of normalization window of tumor vasculature in neoadjuvant chemotherapy for patients with unresectable gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 15:55–58. 2012.(In Chinese). PubMed/NCBI | |
|
Sasaki A, Nakamura Y, Togashi Y, Kuno H, Hojo H, Kageyama S, Nakamura N, Takashima K, Kadota T, Yoda Y, et al: Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer. Gastric Cancer. 23:893–903. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Jain RK: Normalizing tumor microenvironment to treat cancer: Bench to bedside to biomarkers. J Clin Oncol. 31:2205–2218. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yan B, Liu L, Zhao Y, Xiu LJ, Sun DZ, Liu X, Lu Y, Shi J, Zhang YC, Li YJ, et al: Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells. World J Gastroenterol. 20:13105–13118. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Shi J and Wei PK: The phlegm theory of gastric cancer. Zhong Xi Yi Jie He Xue Bao. 9:581–587. 2011.(In Chinese). View Article : Google Scholar : PubMed/NCBI | |
|
State Administration of Traditional Chinese Medicine, . Criteria for Diagnosis and Evaluation of Therapeutic Effect on Diseases and Syndromes in Traditional Chinese Medicine. Nanjing University Press; Nanjing: pp. 9–11. 1994 | |
|
Sun DZ, Jiao JP, Ju DW, Ye M, Zhang X, Xu JY, Lu Y, He J, Wei PK and Yang MH: Tumor interstitial fluid and gastric cancer metastasis: An experimental study to verify the hypothesis of ‘tumor-phlegm microenvironment’. Chin J Integr Med. 18:350–358. 2012.(In Chinese). View Article : Google Scholar : PubMed/NCBI | |
|
Ju DW, Wei PK, Lin HM, Sun DZ, Yu S and Xiu LJ: Effects of Xiaotan Sanjie Decoction on expressions of interleukin-8 and its receptors in gastric tumor xenografts and gastric tissue adjacent to the tumor in mice. Zhong Xi Yi Jie He Xue Bao. 8:74–79. 2010.(In Chinese). View Article : Google Scholar : PubMed/NCBI | |
|
Yu X, Zhao Y, Wei P, Chen M, Jing J, Zhong L, et al: Effects of Xiaotan Sanjie decoction on serum expression levels of IL-8 and TGF-β in gastric tumor xenografts in nude mice. Chin Arch Tradit Chin Med. 36:2382–2385. 2018.(In Chinese). https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFDLAST2018&filename=ZYHS201810021&v=8GUmiMviuOMeRswXcUcanzXDS%25mmd2Bixowvul5WOa%25mmd2BraRlfuEWfwqoBiKhPNA6nOO6Ea | |
|
Ye M, Jiao J, Zhang X, et al: Xiaotan Sanjie decoction inhibit MKN-45 human gastric cancer cells by upregulating TGFβRII in vivo and in vitro. Chin J Clin. 11:596–601. 2017.(In Chinese). https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFDLAST2017&filename=ZLYD201704014&v=SSyny61gLr%25mmd2BD7csH5ElmOXxnrufLy1TFMCFLEq%25mmd2BKRZiigitzRn%25mmd2FLZPmCZon7uwML | |
|
Wang J, Wei P, Li Y and Xu L: Effects of Xiaotan Sanjie decoction on expression of CD44V6 in MKN-45 human gastric cancer nude mouse model. J Chengdu Univ Tradit Chin Med. 27:20–21. 2001.(In Chinese). | |
|
Gui MW, Wei PK, Lu Y, Guo W, Qin ZF and Sun DZ: Effects of Xiaotan Sanjie Decoction-containing serum on proliferation and apoptosis of human gastric cancer cells MKN-45. Zhong Xi Yi Jie He Xue Bao. 8:250–255. 2010.(In Chinese). View Article : Google Scholar : PubMed/NCBI | |
|
Liu X, Xiu LJ, Jiao JP, Zhao J, Zhao Y, Lu Y, Shi J, Li YJ, Ye M, Gu YF, et al: Traditional Chinese medicine integrated with chemotherapy for stage IV non-surgical gastric cancer: A retrospective clinical analysis. J Integr Med. 15:469–475. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Sun DZ, Li SD, Liu Y, Zhang Y, Mei R and Yang MH: Differences in the origin of philosophy between Chinese Medicine and Western medicine: Exploration of the holistic advantages of Chinese medicine. Chin J Integr Med. 19:706–711. 2013.(In Chinese). View Article : Google Scholar : PubMed/NCBI | |
|
World Health Organization, . WHO International Standard Terminologies on Traditional Medicine in the Western Pacific Region, World Health Organization, Western Pacific Region. 2007.https://asiantherapies.org/wp-content/uploads/2021/10/WHO-Terminology-Manual-1.pdf | |
|
Lu A, Jiang M, Zhang C and Chan K: An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis. J Ethnopharmacol. 141:549–556. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Clavey S: Phlegm: Aetiology and symptomatology. In: Fluid Physiology and Pathology in Traditional Chinese Medicine. Churchill Livingstone Elsevier; London: pp. 265–312. 2003 | |
|
Meng Q: Basic Thoery of Traditional Chinese Medicine. China Press of Traditional Chinese Medicine; Beijing: 2005 | |
|
Greenwood MT: Dysbiosis, Spleen Qi, phlegm, and complex difficulties. Med Acupunct. 29:128–137. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yue X and Wei P: Phlegm as the target of gastric cancer. Ti Erh Chun I Ta Hsueh Hsueh Pao. 39:1297–1301. 2018. | |
|
Smyth EC, Nilsson M, Grabsch HI, van Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, et al: Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 20:167–192. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Guner A and Yildirim R: Surgical management of metastatic gastric cancer: Moving beyond the guidelines. Transl Gastroenterol Hepatol. 4:582019. View Article : Google Scholar : PubMed/NCBI | |
|
Andreoli TE: Cecil essentials of medicine. Elsevier; Philadelphia, PA: pp. 440–441. 2010 | |
|
Shi J, Qin Z, Wang X, et al: Clinical observation of TCM treatment of dispersing phlegm and eliminating stagnation on postoperative gastric carcinoma. Chin J Info Tradit Chin Med. 18:14–17. 2011.(In Chinese). https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFD2011&filename=XXYY201110010&v=WYxc3H1bWPb2I7WrEYpn3%25mmd2Bq7b0lH46oPvMqfiqxL2Kfg7dCZ%25mmd2FVE4dYKAbMYdugZR | |
|
Hsu PP and Sabatini DM: Cancer cell metabolism: Warburg and beyond. Cell. 134:703–707. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Gajewski TF, Meng Y, Blank C, Brown I, Kacha A, Kline J and Harlin H: Immune resistance orchestrated by the tumor microenvironment. Immunol Rev. 213:131–145. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Fox JG and Wang TC: Inflammation, atrophy, and gastric cancer. J Clin Invest. 117:60–69. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Bockerstett KA and DiPaolo RJ: Regulation of gastric carcinogenesis by inflammatory cytokines. Cell Mol Gastroenterol Hepatol. 4:47–53. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Sun H, Wang X, Wang X, Xu M and Sheng W: The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer. Cell Death Dis. 13:8742022. View Article : Google Scholar : PubMed/NCBI | |
|
Noël A, Gutiérrez-Fernández A, Sounni NE, Behrendt N, Maquoi E, Lund IK, Cal S, Hoyer-Hansen G and López-Otín C: New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment. Front Pharmacol. 3:1402012. View Article : Google Scholar : PubMed/NCBI | |
|
Bussard KM, Mutkus L, Stumpf K, Gomez-Manzano C and Marini FC: Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res. 18:842016. View Article : Google Scholar : PubMed/NCBI | |
|
Kinoshita H, Hirata Y, Nakagawa H, Sakamoto K, Hayakawa Y, Takahashi R, Nakata W, Sakitani K, Serizawa T, Hikiba Y, et al: Interleukin-6 mediates epithelial-stromal interactions and promotes gastric tumorigenesis. PLoS One. 8:e609142013. View Article : Google Scholar : PubMed/NCBI | |
|
Bai J, Qi J, Yang L, Wang Z, Wang R and Shi Y: A comprehensive review on ethnopharmacological, phytochemical, pharmacological and toxicological evaluation, and quality control of Pinellia ternata (Thunb.) Breit. J Ethnopharmacol. 298:1156502022. View Article : Google Scholar : PubMed/NCBI | |
|
Song S, Huang W, Lu X, Liu J, Zhou J, Li Y and Shu P: A network pharmacology study based on the mechanism of Citri Reticulatae Pericarpium-Pinelliae Rhizoma in the treatment of gastric cancer. Evid Based Complement Alternat Med. 2021:66675602021. View Article : Google Scholar : PubMed/NCBI | |
|
Ayeka PA, Bian Y, Githaiga PM and Zhao Y: The immunomodulatory activities of licorice polysaccharides (Glycyrrhiza uralensis Fisch.) in CT 26 tumor-bearing mice. BMC Complement Altern Med. 17:5362017. View Article : Google Scholar : PubMed/NCBI | |
|
Park A, Yang Y, Lee Y, Jung H, Kim TD, Noh JY, Lee S and Yoon SR: Aurantii Fructus Immaturus enhances natural killer cytolytic activity and anticancer efficacy in vitro and in vivo. Front Med (Lausanne). 9:9736812022. View Article : Google Scholar : PubMed/NCBI | |
|
Ding J, Chua PJ, Bay BH and Gopalakrishnakone P: Scorpion venoms as a potential source of novel cancer therapeutic compounds. Exp Biol Med (Maywood). 239:387–393. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Rapôso C: Scorpion and spider venoms in cancer treatment: State of the art, challenges, and perspectives. J Clin Transl Res. 3:233–249. 2017.PubMed/NCBI | |
|
Zhao H, Li Y, Wang Y, Zhang J, Ouyang X, Peng R and Yang J: Antitumor and immunostimulatory activity of a polysaccharide-protein complex from Scolopendra subspinipes mutilans L. Koch in tumor-bearing mice. Food Chem Toxicol. 50:2648–2655. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bokhari AA and Syed V: Inhibition of transforming growth factor-β (TGF-β) signaling by Scutellaria baicalensis and Fritillaria cirrhosa Extracts in endometrial cancer. J Cell Biochem. 116:1797–1805. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Cao S, Zheng B, Chen T, Chang X, Yin B, Huang Z, Shuai P and Han L: Semen Brassicae ameliorates hepatic fibrosis by regulating transforming growth factor-β1/Smad, nuclear factor-κB, and AKT signaling pathways in rats. Drug Des Devel Ther. 12:1205–1213. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Xiao Y, Wei P, Li Y, He J, Xu L and Qin Z: Influence of Xiaotan Sanjie decoction on the expression of matrix metalloproteinase and inhibitor in Gastric Carcinoma. Hubei J Tradit Chin Med. 34:8–10. 2005. | |
|
Ju D, Xiu L, Sun D, Lu Y and Wei P: Effects of Xiaotan Sanjie decoction on invasive ability of human gastric cancer cell line SGC-7901. Chin J Woman Child Health Res. 27:343–344. 2016.(In Chinese). | |
|
Tang J, Wei P and Zhang Y: Effects of Xiaotan Sanjie decoction on microvessel density and expression level of VEGF-A/VEGFR-2. World J Integr Tradit Western Med. 10:346–349. 2015. | |
|
Xu L, Su X, Chen Y and Wei P: Xiaotan Sanjie decoction downregulate expression level of VEGF, KDRmRNA in orthotopic human gastric carcinoma in nude mice. World Chin J Digest. 12:32004.(In Chinese). | |
|
Pang B, Wei P, Mao Z and Li Y: Effects of Xiaotan Sanjie Decoction on expression levels of VEGF-D in MKN45 ×enografts in nude mice. Chin J Inf Tradit Chin Med. 18:42–44. 2011.(In Chinese). | |
|
Zhou W, Li YJ and Wei PK: Effects of xiaotan sanjie decoction on vasculogenic mimicry of human gastric cancer xenografts in nude mice. Zhongguo Zhong Xi Yi Jie He Za Zhi. 31:532–536. 2011.(In Chinese). PubMed/NCBI | |
|
Kumar V, Ramnarayanan K, Sundar R, Padmanabhan N, Srivastava S, Koiwa M, Yasuda T, Koh V, Huang KK, Tay ST, et al: Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer. Cancer Discov. 12:670–691. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Gu J, Wang C, Xu X, Zhao L, Zhou J, Bai C and Sun Z: Immunohistochemical detection of cancer-associated fibroblasts in gastrointestinal cancer as a potential prognostic biomarker of survival: Meta-analysis. Transl Cancer Res. 9:6629–6638. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wen X, He X, Jiao F, Wang C, Sun Y, Ren X and Li Q: Fibroblast activation Protein-a-positive fibroblasts promote gastric cancer progression and resistance to immune checkpoint blockade. Oncol Res. 25:629–640. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Z, Zhao Y, Hu X, Shao Z, Jiang Z, Lu Y, Xiao Z, Pang B, et al: Effects of Xiaotan Sanjie decoction on expression of fibroblast activation protein α in gastric cancer MKN-45 cells xenografted in nude mice. Chin Arch Tradit Chin Med. 28:331–334. 2010.(In Chinese). https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFD2010&filename=ZYHS201002050&v=CTYLMbKoZXwaH0%25mmd2FV8SFqFzODQhR2nxC%25mmd2FPoPnpAkNeO7fQrS0ZGsv7vUfMkTs49D0 | |
|
French R, Feng Y and Pauklin S: Targeting TGFβ signaling in cancer: Toward context-specific strategies. Trends Cancer. 6:538–540. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Saito H, Tsujitani S, Oka S, Kondo A, Ikeguchi M, Maeta M and Kaibara N: An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma. Anticancer Res. 20:4489–4493. 2000.PubMed/NCBI | |
|
Evans RA, Tian YC, Steadman R and Phillips AO: TGF-β1-mediated fibroblast-myofibroblast terminal differentiation-the role of smad proteins. Exp Cell Res. 282:90–100. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Yang L, Chang N, Liu X, Han Z, Zhu T, Li C, Yang L and Li L: Bone marrow-derived mesenchymal stem cells differentiate to hepatic myofibroblasts by transforming growth factor-β1 via sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis. Am J Pathol. 181:85–97. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Jotzu C, Alt E, Welte G, Li J, Hennessy BT, Devarajan E, Krishnappa S, Pinilla S, Droll L and Song YH: Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors. Cell Oncol (Dordr). 34:55–67. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Calon A, Tauriello DV and Batlle E: TGF-beta in CAF-mediated tumor growth and metastasis. Semin Cancer Biol. 25:15–22. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Piek E, Heldin CH and Ten Dijke P: Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J. 13:2105–2124. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Massagué J, Seoane J and Wotton D: Smad transcription factors. Gene Dev. 19:2783–2810. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Elliott RL and Blobe GC: Role of transforming growth factor Beta in human cancer. J Clin Oncol. 23:2078–2093. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Pickup M, Novitskiy S and Moses HL: The roles of TGFβ in the tumour microenvironment. Nat Rev Cancer. 13:788–799. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bierie B and Moses HL: TGF-β and cancer. Cytokine Growth Factor Rev. 17:29–40. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Park K, Kim SJ, Bang YJ, Park JG, Kim NK, Roberts AB and Sporn MB: Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-beta. Proc Natl Acad Sci USA. 91:8772–8776. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Nadauld LD, Garcia S, Natsoulis G, Bell JM, Miotke L, Hopmans ES, Xu H, Pai RK, Palm C, Regan JF, et al: Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer. Genome Biol. 15:4282014. View Article : Google Scholar : PubMed/NCBI | |
|
Kim SH, Lee SH, Choi YL, Wang LH, Park CK and Shin YK: Extensive alteration in the expression profiles of TGFB pathway signaling components and TP53 is observed along the gastric dysplasia-carcinoma sequence. Histol Histopathol. 23:1439–1452. 2008.PubMed/NCBI | |
|
Pak KH, Kim DH, Kim H, Lee DH and Cheong JH: Differences in TGF-β1 signaling and clinicopathologic characteristics of histologic subtypes of gastric cancer. BMC Cancer. 16:602016. View Article : Google Scholar : PubMed/NCBI | |
|
Yan YQ, Xie J, Wang JF, Shi ZF, Zhang X, Du YP and Zhao XC: Scorpion inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Exp Biol Med (Maywood). 243:645–654. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Karakasheva TA, Lin EW, Tang Q, Qiao E, Waldron TJ, Soni M, Klein-Szanto AJ, Sahu V, Basu D, Ohashi S, et al: IL-6 mediates cross-talk between tumor cells and activated fibroblasts in the tumor microenvironment. Cancer Res. 78:4957–4970. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ju D, Wei P, Sun D, Lin H and Yu S: Effects of Xiaotan Sanjie decoction on IL-6 gene expression in tumor and adjacent tissues of S180 tumor-bearing mice model. Chin J Integr Dig. 15:284–288. 2008.(In Chinese). | |
|
Li S, Zheng M, Zhang Z, Peng H, Dai W and Liu J: Galli gigeriae endothelium corneum: Its intestinal barrier protective activity in vitro and chemical composition. Chin Med. 16:222021.(In Chinese). View Article : Google Scholar : PubMed/NCBI | |
|
Yu JY, Ha JY, Kim KM, Jung YS, Jung JC and Oh S: Anti-Inflammatory activities of licorice extract and its active compounds, glycyrrhizic acid, liquiritin and liquiritigenin, in BV2 cells and mice liver. Molecules. 20:13041–13054. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kitadai Y, Takahashi Y, Haruma K, Naka K, Sumii K, Yokozaki H, Yasui W, Mukaida N, Ohmoto Y, Kajiyama G, et al: Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer. 81:647–653. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z, Hou Y, Yao Z, Zhan Y, Chen W and Liu Y: Expressivity of Interleukin-8 and gastric cancer prognosis susceptibility: A systematic review and meta-analysis. Dose Response. 19:155932582110371272021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhai J, Shen J, Xie G, Wu J, He M, Gao L, Zhang Y, Yao X and Shen L: Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer. Cancer Lett. 454:37–43. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Shi J and Wei PK: Xiaotan Sanjie decoction inhibits interleukin-8-induced metastatic potency in gastric cancer. World J Gastroenterol. 21:1479–1487. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lynch MD and Watt FM: Fibroblast heterogeneity: Implications for human disease. J Clin Investig. 128:26–35. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Voloshenyuk TG, Landesman ES, Khoutorova E, Hart AD and Gardner JD: Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling. Cytokine. 55:90–97. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Najafi M, Farhood B and Mortezaee K: Extracellular matrix (ECM) stiffness and degradation as cancer drivers. J Cell Biochem. 120:2782–2790. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Huang J, Zhang L, Wan D, Zhou L, Zheng S, Lin S and Qiao Y: Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduct Target Ther. 6:1532021. View Article : Google Scholar : PubMed/NCBI | |
|
Balazs EA, Laurent TC and Jeanloz RW: Nomenclature of hyaluronic acid. Biochem J. 235:9031986. View Article : Google Scholar : PubMed/NCBI | |
|
Setälä LP, Tammi MI, Tammi RH, Eskelinen MJ, Lipponen PK, Agren UM, Parkkinen J, Alhava EM and Kosma VM: Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer. 79:1133–1138. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Eikenes L, Tufto I, Schnell EA, Bjørkøy A and De Lange Davies C: Effect of collagenase and hyaluronidase on free and anomalous diffusion in multicellular spheroids and xenografts. Anticancer Res. 30:359–368. 2010.PubMed/NCBI | |
|
Jacobetz MA, Chan DS, Neesse A, Bapiro TE, Cook N, Frese KK, Feig C, Nakagawa T, Caldwell ME, Zecchini HI, et al: Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut. 62:112–120. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao R, Cui Y, Zheng Y, Li S, Lv J, Wu Q, Long Y, Wang S, Yao Y, Wei W, et al: Human Hyaluronidase PH20 potentiates the antitumor activities of Mesothelin-specific CAR-T cells against gastric cancer. Front Immunol. 12:6604882021. View Article : Google Scholar : PubMed/NCBI | |
|
Wright RP, Chan TK, Honetschlager L, Howell DE and Odell GV: Enzymes and toxins of the scorpion venom Palamneus gravimanus. Toxicon. 15:197–205. 1977. View Article : Google Scholar : PubMed/NCBI | |
|
González-Morales L, Pedraza-Escalona M, Diego-Garcia E, Restano-Cassulini R, Batista CV, Gutiérrez Mdel C and Possani LD: Proteomic characterization of the venom and transcriptomic analysis of the venomous gland from the Mexican centipede Scolopendra viridis. J Proteomics. 111:224–237. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Naor D, Sionov RV and Ish-Shalom D: CD44: Structure, function, and association with the malignant process. Adv Cancer Res. 71:241–319. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Y, Fu Z, Xu S, Xu Y and Xu P: The prognostic value of CD44 expression in gastric cancer: A meta-analysis. Biomed Pharmacother. 68:693–697. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Misra S, Heldin P, Hascall VC, Karamanos NK, Skandalis SS, Markwald RR and Ghatak S: Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J. 278:1429–1443. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang S, Wei P, He J, Xiao Y, Chen G, Gu J, et al: Effects of Jinlongshe formula on tumor proliferation and metastases and expression of cell adhesion molecules in MKN-45 human gastric cancer nude mouse model. Tumor. 25:519–524. 2006.https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFD2006&filename=ZZLL200606006&v=s1YASjhB7tsvRqd%25mmd2F%25mmd2BMg%25mmd2Fq8XnD2Vn96oB%25mmd2BffZf4A4Bh7qvD40ECTEqijOPzzUCyqD | |
|
Lukaszewicz-Zając M, Mroczko B and Szmitkowski M: Gastric cancer- The role of matrix metalloproteinases in tumor progression. Clin Chim Acta. 412:1725–1730. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, Selig M, Nielsen G, Taksir T, Jain RK and Seed B: Tumor induction of VEGF promoter activity in stromal cells. Cell. 94:715–725. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao Y, Wang X, Lu Y, Liu X, Xiu L, Yue X, et al: Xiaotan Sanjie decoction on quality of life in patients with advanced gastric cancer. Ti Erh Chun I Ta Hsueh Hsueh Pao. 37:1333–1337. 2016.(In Chinese). https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFDLAST2017&filename=DEJD201611003&v=kQr6y0QoJCwsnabe8RyD3I5ziphgCCMRnPcPGOv3wTJP8Apz2l2jK77cElywgR16 | |
|
Wu F, Qin Z, Zhang C, Yan B, Shen W and Wei P: Effects of Jinlongshe formulae on quality of life in patients with gastric cancer after gastric resection. Chin J Integr Tradit Western Med Digest. 20:289–292. 2012.(In Chinese). | |
|
Shi J, Qin Z, Wang X, Zhang Y, Zhang C, Wang D, et al: Xiaotan Sanjie decoction in patients with gastric cancer after gastric resection. Chin J Info Tradit Chin Med. 18:14–17. 2011.(In Chinese). https://kns.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&dbname=CJFD2011&filename=XXYY201110010&v=WYxc3H1bWPb2I7WrEYpn3%25mmd2Bq7b0lH46oPvMqfiqxL2Kfg7dCZ%25mmd2FVE4dYKAbMYdugZR | |
|
Li X and Wei P: Jinlongshe formulae in advanced gastric cancer. Hubei J Tradit Chin Med. 23:3–5. 2001.(In Chinese). | |
|
Xu L, Chen Y, Liu Y, Qin Z, Li J, Shi J, et al: Efficacy of Xiaotan Sanjie decoction combined with Huangqi injection and Huachansu injection in patients with stage IV gastric cancer. J Chengdu Univ Tradit Chin Med. 28:7–9. 2005.(In Chinese). https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C44YLTlOAiTRKgchrJ08w1e7F1IFNsBV5UtixLZQlfT5Bp4RioHTO7MFcAQH76h6XVw4s4ZTzR4S80OigHx_bgBm&uniplatform=NZKPT | |
|
Sun DZ, Jiao JP, Zhang X, Xu JY, Ye M, Xiu LJ, Zhao Y, Lu Y, Liu X, Zhao J, et al: Therapeutic effect of Jinlongshe granule on quality of life of stage IV gastric cancer patients using EORTC QLQ-C30: A double-blind placebo-controlled clinical trial. Chin J Integr Med. 21:579–586. 2015.(In Chinese). View Article : Google Scholar : PubMed/NCBI | |
|
Liu X, Xiu LJ, Jiao JP, Zhao J, Zhao Y, Lu Y, Shi J, Li YJ, Ye M, Gu YF, et al: Traditional Chinese medicine integrated with chemotherapy for stage IV non-surgical gastric cancer: A retrospective clinical analysis. J Integr Med. 15:469–475. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Sun DZ, Ju DW, He J, Lu Y, Wu F, Li C and Wei PK: Tumor interstitial fluid and postoperative recurrence of tumors: An experimental study for verifying hypothesis of ‘Tumor-phlegm Microenvironment’. Chin J Integr Med. 16:435–441. 2010.(In Chinese). View Article : Google Scholar : PubMed/NCBI | |
|
Koelzer VH, Sirinukunwattana K, Rittscher J and Mertz KD: Precision immunoprofiling by image analysis and artificial intelligence. Virchows Archiv. 474:511–522. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lin L and Wang LV: The emerging role of photoacoustic imaging in clinical oncology. Nat Rev Clin Oncol. 19:365–384. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Qi CY, Wang J, Wu X, He SR, Zhang Q, Wu JH and Zhao CB: Botanical, traditional use, phytochemical, and toxicological of Arisaematis rhizoma. Evid Based Complement Alternat Med. 2021:90555742021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Li T, Zhao Y, Zhang J and Liu H: Contents of some metabolites in the peel and flesh of the medicinal mushroom Wolfiporia cocos (F.A. Wolf) Ryvarden et Gilb. (Higher Basidiomycetes). Int J Med Mushrooms. 14:79–83. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bian C, Xie N and Chen F: Preparation of bioactive water-soluble pachyman hydrolyzed from sclerotial polysaccharides of Poria cocos by hydrolase. Polym J. 42:256–260. 2010. View Article : Google Scholar | |
|
Wagner H, Püls S, Barghouti T, Staudinger A and Melchart D: Chromatographic Fingerprint Analysis of Herbal Medicines. Springer; Vienna: pp. 31–44. 2018 | |
|
Duan L, Guo L, Liu K, Liu EH and Li P: Characterization and classification of seven citrus herbs by liquid chromatography-quadrupole time-of-flight mass spectrometry and genetic algorithm optimized support vector machines. J Chromatogr A. 1339:118–127. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hao EW, Su ZX, Gong YL, Du ZC, Yang X, Huang CT, Hou XT and Deng JG: Analysis on application law of dampness-removing traditional Chinese medicines in treatment of coronavirus disease 2019. Chin Herb Med. 13:518–524. 2021.(In Chinese). View Article : Google Scholar : PubMed/NCBI | |
|
Song L, Xiong P, Zhang W, Hu H, Tang S, Jia B and Huang W: Mechanism of Citri Reticulatae Pericarpium as an anticancer agent from the perspective of flavonoids: A review. Molecules. 27:56222022. View Article : Google Scholar : PubMed/NCBI | |
|
Moon JY and Cho SK: Nobiletin Induces protective autophagy accompanied by ER-stress mediated apoptosis in human gastric cancer SNU-16 cells. Molecules. 21:9142016. View Article : Google Scholar : PubMed/NCBI | |
|
Dong Y, Cao A, Shi J, Yin P, Wang L, Ji G, Xie J and Wu D: Tangeretin, a citrus polymethoxyflavonoid, induces apoptosis of human gastric cancer AGS cells through extrinsic and intrinsic signaling pathways. Oncol Rep. 31:1788–1794. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yu W, Xie X, Yu Z, Jin Q and Wu H: Mechanism of hesperidin-induced apoptosis in human gastric cancer AGS cells. Trop J Pharm Res. 50:2363–2369. 2019. | |
|
Xiong Q, Li X, Zhou R, Hao H, Li S, Jing Y, Zhu C, Zhang Q and Shi Y: Extraction, characterization and antioxidant activities of polysaccharides from E. corneum gigeriae galli. Carbohydr Polym. 108:247–256. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Chen T, Zhong F, Yao C, Chen J, Xiang Y, Dong J, Yan Z and Ma Y: A systematic review on traditional uses, sources, phytochemistry, pharmacology, pharmacokinetics, and toxicity of Fritillariae Cirrhosae Bulbus. Evid Based Complement Alternat Med. 2020:15365342020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang D, Chen X, Atanasov AG, Yi X and Wang S: Plant resource availability of medicinal Fritillaria species in traditional producing regions in Qinghai-Tibet plateau. Front Pharmacol. 8:5022017. View Article : Google Scholar : PubMed/NCBI | |
|
Li R, Zhang Y, Wang Y, Huang K, Yang Q, Zhang T, Xie K, Li J and Zhao Q: Aqueous extract of Fritillariae cirrhosae induces cellular apoptosis through activation of STATs-mediated immunomodulation. J Ethnopharmacol. 261:1123382020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Zhang H, Chen L, Shan L, Fan G and Gao X: Liquorice, a unique ‘guide drug’ of traditional Chinese medicine: A review of its role in drug interactions. J Ethnopharmacol. 150:781–790. 2013. View Article : Google Scholar : PubMed/NCBI |
